Skip to content
High Tech Series A Founded 2014

Ultralytics

Ultralytics provides an end-to-end computer vision platform that enables organizations to annotate data, train YOLO models, and deploy AI solutions globally. As the creator of the widely adopted YOLO model family (YOLOv5, YOLOv8, YOLO11, and YOLO26), Ultralytics has become the standard in vision AI with over 131,600 GitHub stars, 308 million downloads, and 3.3 billion daily YOLO usages. The platform offers smart…

📍 Frederick, United States · AI Infrastructure,

Funding snapshot

Last roundSeries A
Amount$30M
Date17 September 2025
Total raised$30M
Team size64

About

Ultralytics provides an end-to-end computer vision platform that enables organizations to annotate data, train YOLO models, and deploy AI solutions globally. As the creator of the widely adopted YOLO model family (YOLOv5, YOLOv8, YOLO11, and YOLO26), Ultralytics has become the standard in vision AI with over 131,600 GitHub stars, 308 million downloads, and 3.3 billion daily YOLO usages. The platform offers smart annotation tools with SAM-powered one-click detection, cloud-accelerated training across 26 GPU configurations, and deployment to 42 global regions with auto-scaling and real-time monitoring. Models can be exported to 20 formats including ONNX, TensorRT, CoreML, and LiteRT for edge, mobile, and embedded devices. The platform supports seven AI tasks: object detection, instance segmentation, semantic segmentation, depth estimation, image classification, pose estimation, and oriented object detection. Ultralytics serves industries including robotics, logistics, retail, healthcare, manufacturing, automotive, and agriculture. The company holds ISO 27001 and SOC 2 Type I certifications. Founded in 2014 and headquartered in Frederick, Maryland, Ultralytics has raised $30 million in Series A funding from investors including SquareOne and Elephant Venture Capital.

Business model

AI Infrastructure > Computer Vision > Computer Vision Platform

Institutional investors

SquareOne Elephant Venture Capital

Latest coverage

No articles yet.

Raising like Ultralytics?

Analyze your pitch deck before your next raise.

Analyze My Deck →